Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Cardiovascular Diseases  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Knopman DS, Mosley TH, Catellier DJ, A Sharrett R. "Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort." Neurology. 2005;65(6):876-81.
Gregson J, Kaptoge S, Bolton T, et al. "Cardiovascular Risk Factors Associated With Venous Thromboembolism." JAMA Cardiol. 2019;4(2):163-173.
Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. "Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study." Am J Epidemiol. 1991;134(3):250-6.
Kong L, Cai J. "Case-cohort analysis with accelerated failure time model." Biometrics. 2009;65(1):135-42.
Yazdani A, Yazdani A. "A Causal Network Analysis of the Fatty Acid Metabolome in African-Americans Reveals a Critical Role for Palmitoleate and Margarate." OMICS. 2016;20(8):480-4.
Liu S, Kim ED, Wu A, et al. "Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults." PLoS One. 2019;14(2):e0212892.
Rebholz CM, Grams ME, Matsushita K, et al. "Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality." Clin J Am Soc Nephrol. 2015;10(6):941-8.
Stevens J, Cai J. "Changes in body mass index prior to baseline among participants who are ill or who die during the early years of follow-up." Am J Epidemiol. 2001;153(10):946-53.
Alonso A, Misialek JR, Eckfeldt JH, et al. "Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study." J Am Heart Assoc. 2014;3(5):e001082.
Hui X, Matsushita K, Sang Y, Ballew SH, Fulop T. "CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race." Am J Kidney Dis. 2013;62(4):691-702.
Yang EY, Nambi V, Tang Z, et al. "Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study." J Am Coll Cardiol. 2009;54(25):2388-95.
Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD. "Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence." J Am Coll Cardiol. 2011;57(16):1690-6.
Matsushita K, Mahmoodi BK, Woodward M, et al. "Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate." JAMA. 2012;307(18):1941-51.
Nunez E, Arnett DK, Benjamin EJ, Oakes MJ, Liebson PR, Skelton TN. "Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women." Am J Cardiol. 2004;94(11):1383-90.
Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Wu KK. "Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Thromb Haemost. 1993;70(5):762-7.
Patel S, Kwak L, Agarwal SK, Tereshchenko LG, Coresh JJ, Soliman EZ. "Counterclockwise and Clockwise Rotation of QRS Transitional Zone: Prospective Correlates of Change and Time-Varying Associations With Cardiovascular Outcomes." J Am Heart Assoc. 2017;6(11).
White IR. "Covariate-adjusted measures of discrimination for survival data." Biom J. 2015;57(4):592-613.
Kaptoge S, Di Angelantonio E, Pennells L, et al. "C-reactive protein, fibrinogen, and cardiovascular disease prediction." N Engl J Med. 2012;367(14):1310-20.
van der Laan SW, Fall T, Soumaré A, et al. "Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study." J Am Coll Cardiol. 2016;68(9):934-45.
D
"The decline of ischaemic heart disease mortality in the ARIC study communities. The ARIC Study Investigators." Int J Epidemiol. 1989;18(3 Suppl 1):S88-98.
Fowkes FGR, Murray GD, Butcher I, et al. "Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events." Eur J Prev Cardiol. 2014;21(3):310-20.
Fox ER, Samdarshi TE, Musani SK, et al. "Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort." JAMA Cardiol. 2016;1(1):15-25.
Liese AD, Mayer-Davis EJ, Tyroler HA, et al. "Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Atherosclerosis risk in communities." Ann Epidemiol. 1997;7(6):407-16.
Jackson R, Chambless LE, Yang K, et al. "Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." J Clin Epidemiol. 1996;49(12):1441-46.
George KM, Folsom AR, Steffen LM, Wagenknecht LE. "Differences in Cardiovascular Mortality Risk among African Americans in the Minnesota Heart Survey: 1985-2015 vs The Atherosclerosis Risk in Communities Study Cohort: 1987-2015." Ethn Dis. 2019;29(1):47-52.
Cheng S, Gupta DK, Claggett B, et al. "Differential influence of distinct components of increased blood pressure on cardiovascular outcomes: from the atherosclerosis risk in communities study." Hypertension. 2013;62(3):492-8.
Bis JC, Sitlani C, Irvin R, et al. "Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium." PLoS One. 2015;10(10):e0140496.
E
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. "Early-life and adult socioeconomic status and inflammatory risk markers in adulthood." Eur J Epidemiol. 2007;22(1):55-66.
Shahar E, Folsom AR, Jackson R. "The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Atherosclerosis Risk in Communities (ARIC) Study Investigators." Ann Epidemiol. 1996;6(6):498-506.
O'Neal WT, Wang YGrace, Wu H-T, et al. "Electrocardiographic J Wave and Cardiovascular Outcomes in the General Population (from the Atherosclerosis Risk In Communities Study)." Am J Cardiol. 2016;118(6):811-815.
Rautaharju PM, Zhang Z-M, Warren J, et al. "Electrocardiographic predictors of coronary heart disease and sudden cardiac deaths in men and women free from cardiovascular disease in the Atherosclerosis Risk in Communities study." J Am Heart Assoc. 2013;2(3):e000061.
Cowan LT, Lakshminarayan K, Lutsey PL, Beck J, Offenbacher S. "Endodontic therapy and incident cardiovascular disease: The Atherosclerosis Risk in Communities (ARIC) study." J Public Health Dent. 2020;80(1):79-91.
Srinath R, Golden SHill, Carson KA. "Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study." J Clin Endocrinol Metab. 2015;100(4):1602-8.
Matsushita K, Coresh JJ, Sang Y, et al. "Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data." Lancet Diabetes Endocrinol. 2015;3(7):514-25.
Barrett JK, Huille R, Parker R, Yano Y. "Estimating the association between blood pressure variability and cardiovascular disease: An application using the ARIC Study." Stat Med. 2019;38(10):1855-1868.
Buyske S, Wu Y, Carty CL, et al. "Evaluation of the metabochip genotyping array in African Americans and implications for fine mapping of GWAS-identified loci: the PAGE study." PLoS One. 2012;7(4):e35651.
F
George KM, Folsom AR, Kucharska-Newton AMaria, Mosley TH. "Factors Related to Differences in Retention among African American and White Participants in the Atherosclerosis Risk in Communities Study (ARIC) Prospective Cohort: 1987-2013." Ethn Dis. 2017;27(1):31-38.
Nabulsi AA, Folsom AR, Heiss G, et al. "Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Atherosclerosis Risk in Communities Study Investigators." Metabolism. 1995;44(7):914-22.
Lutsey PL, Alonso A, Selvin E, et al. "Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study." J Am Heart Assoc. 2014;3(3):e000936.
Honda Y, Mok Y, Ishigami J, et al. "The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community." J Am Coll Cardiol. 2021;78(20):2019-2021.
Evans DS, Avery CL, Nalls MA, et al. "Fine-mapping, novel loci identification, and SNP association transferability in a genome-wide association study of QRS duration in African Americans." Hum Mol Genet. 2016;25(19):4350-4368.
Rapsomaniki E, White IR, Wood AM, Thompson SG. "A framework for quantifying net benefits of alternative prognostic models." Stat Med. 2012;31(2):114-30.
Savoca MR, Steffen LM, Bertoni AG. "From Neighborhood to Genome: Three Decades of Nutrition-Related Research from the Atherosclerosis Risk in Communities Study." J Acad Nutr Diet. 2017;117(12):1881-1886.e10.
G
Sitlani CM, Rice KM, Lumley T, et al. "Generalized estimating equations for genome-wide association studies using longitudinal phenotype data." Stat Med. 2015;34(1):118-30.
Yazdani A, Yazdani A, Samiei A. "Generating a robust statistical causal structure over 13 cardiovascular disease risk factors using genomics data." J Biomed Inform. 2016;60:114-9.
Evangelou E, Warren HR, Mosen-Ansorena D, et al. "Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits." Nat Genet. 2018;50(10):1412-1425.
Weng L-C, Tang W, Rich SS, et al. "A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups." Thromb Res. 2014;134(2):462-7.
Allen NB, Lloyd-Jones D, Hwang S-J, et al. "Genetic loci associated with ideal cardiovascular health: A meta-analysis of genome-wide association studies." Am Heart J. 2016;175:112-20.
Li C, Grove ML, Yu B, Jones BC, Morrison A, Boerwinkle E. "Genetic variants in microRNA genes and targets associated with cardiovascular disease risk factors in the African-American population." Hum Genet. 2018;137(1):85-94.
Ehret GB, Munroe PB, Rice KM, et al. "Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk." Nature. 2011;478(7367):103-9.
Seidelmann SB, Feofanova E, Yu B, et al. "Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk." J Am Coll Cardiol. 2018;72(15):1763-1773.
Schunk SJ, Kleber ME, März W, et al. "Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality." Eur Heart J. 2021;42(18):1742-1756.
Maruthur NM, Li M, Halushka MK, et al. "Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study." PLoS One. 2015;10(6):e0128452.
Köttgen A, Kao W HL, Hwang S-J, et al. "Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies." BMC Med Genet. 2008;9:49.
Huan T, Joehanes R, Song C, et al. "Genome-wide identification of DNA methylation QTLs in whole blood highlights pathways for cardiovascular disease." Nat Commun. 2019;10(1):4267.
Selvin E, Steffes MW, Zhu H, et al. "Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults." N Engl J Med. 2010;362(9):800-11.
Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW. "Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study." Diabetes Care. 2005;28(8):1965-73.
Oyenuga AO, Folsom AR, Cheng S, Tanaka H. "Greater Adherence to Life's Simple 7 Is Associated With Less Arterial Stiffness: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Hypertens. 2019;32(8):769-776.
I
Shah AM, Claggett B, Folsom AR, Lutsey PL, Ballantyne CM, Heiss G. "Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the Elderly." Circulation. 2015;132(21):1979-89.
Rasmussen-Torvik LJ, Shay CM, Abramson JG, et al. "Ideal cardiovascular health is inversely associated with incident cancer: the Atherosclerosis Risk In Communities study." Circulation. 2013;127(12):1270-5.
Corona G, Rastrelli G, Silverii A, et al. "The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction." J Sex Med. 2013;10(4):1114-23.
Huxley RR, Yatsuya H, Lutsey PL, Woodward M, Alonso A, Folsom AR. "Impact of age at smoking initiation, dosage, and time since quitting on cardiovascular disease in african americans and whites: the atherosclerosis risk in communities study." Am J Epidemiol. 2012;175(8):816-26.
Ogunwale AN, Morrison AC, Sun W, et al. "The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study." Eur J Prev Cardiol. 2016;23(14):1529-36.
Han E, Truesdale KP, Taber DR, Cai J, Juhaeri J, Stevens J. "Impact of overweight and obesity on hospitalization: race and gender differences." Int J Obes (Lond). 2009;33(2):249-56.
Folsom AR, Burke GL, Byers CL, et al. "Implications of obesity for cardiovascular disease in blacks: the CARDIA and ARIC studies." Am J Clin Nutr. 1991;53(6 Suppl):1604S-1611S.
Rywik SL, Williams OD, Pajak A, et al. "Incidence and correlates of hypertension in the Atherosclerosis Risk in Communities (ARIC) study and the Monitoring Trends and Determinants of Cardiovascular Disease (POL-MONICA) project." J Hypertens. 2000;18(8):999-1006.
Adeniyi A, Folsom AR, Brancati FL, Desvorieux M, Pankow JS, Taylor H. "Incidence and risk factors for cardiovascular disease in African Americans with diabetes: the Atherosclerosis Risk in Communities (ARIC) study." J Natl Med Assoc. 2002;94(12):1025-35.
Ishigami J, Cowan LT, Demmer RT, et al. "Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome." J Am Soc Nephrol. 2020;31(2):405-414.
E Estes H, Zhang Z-M, Li Y, Tereshchenko LG. "Individual components of the Romhilt-Estes left ventricular hypertrophy score differ in their prediction of cardiovascular events: The Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2015;170(6):1220-6.
Cowan LT, Lutsey PL, Pankow JS, Matsushita K, Ishigami J. "Inpatient and Outpatient Infection as a Trigger of Cardiovascular Disease: The ARIC Study." J Am Heart Assoc. 2018;7(22):e009683.
Huan T, Nguyen S, Colicino E, et al. "Integrative analysis of clinical and epigenetic biomarkers of mortality." Aging Cell. 2022;21(6):e13608.
Mok Y, Ballew SH, Bash LD, et al. "International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee." J Am Heart Assoc. 2018;7(14).
K
Alexander N, Matsushita K, Sang Y, Ballew S, Mahmoodi BK, Astor BC. "Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study." Am J Nephrol. 2015;41(4-5):409-17.

Pages